Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Armando Lopez-Guillermo

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|January 25, 2013
Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphomaSilvia Fuertes, Xavier Setoain, Armando Lopez-Guillermo, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2004
Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factorsEric M Bessell, Francesc Graus, Armando Lopez-Guillermo, et al.
Anticancer Research|February 26, 2004
Low p27 expression predicts biochemical relapse after radical prostatectomy in patients with clinically localised prostate cancerMaria J Ribal, Pedro L Fernandez, Armando Lopez-Guillermo, et al.
Leukemia & Lymphoma|April 10, 2024
Safety and efficacy of parsaclisib in combination with rituximab, bendamustine + rituximab, or ibrutinib in patients with previously treated B-cell lymphoma: analysis of a phase 1 dose-finding study (CITADEL‑112)Juan-Manuel Sancho, Pau Abrisqueta, Abhijeet Kumar, et al.
Leukemia Research|September 4, 2012
Retreatment with purine analogs in patients with chronic lymphocytic leukemiaIvan Dlouhy, Gabriela Ghita, Tycho Baumann, et al.
Blood|July 11, 2006
High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphomaJoaquim Carreras, Armando Lopez-Guillermo, Bridget C Fox, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphomaJoaquim Carreras, Armando Lopez-Guillermo, Giovanna Roncador, et al.
The American Journal of Pathology|April 25, 2009
Activation of the endoplasmic reticulum stress-associated transcription factor x box-binding protein-1 occurs in a subset of normal germinal-center B cells and in aggressive B-cell lymphomas with prognostic implicationsOlga Balague, Ana Mozos, Daniel Martinez, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 14, 2017
HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphomaBlanca Gonzalez-Farre, Daniel Martinez, Monica Lopez-Guerra, et al.
Journal of Nephrology|January 29, 2014
Primary brain lymphomas after kidney transplantation: an under-recognized problem?Nuria Sola-Valls, Néstor Yesid Rodríguez C, Carola Arcal, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
European Journal of Nuclear Medicine and Molecular Imaging|January 25, 2013
Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphomaSilvia Fuertes, Xavier Setoain, Armando Lopez-Guillermo, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2004
Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factorsEric M Bessell, Francesc Graus, Armando Lopez-Guillermo, et al.
Anticancer Research|February 26, 2004
Low p27 expression predicts biochemical relapse after radical prostatectomy in patients with clinically localised prostate cancerMaria J Ribal, Pedro L Fernandez, Armando Lopez-Guillermo, et al.
Leukemia & Lymphoma|April 10, 2024
Safety and efficacy of parsaclisib in combination with rituximab, bendamustine + rituximab, or ibrutinib in patients with previously treated B-cell lymphoma: analysis of a phase 1 dose-finding study (CITADEL‑112)Juan-Manuel Sancho, Pau Abrisqueta, Abhijeet Kumar, et al.
Leukemia Research|September 4, 2012
Retreatment with purine analogs in patients with chronic lymphocytic leukemiaIvan Dlouhy, Gabriela Ghita, Tycho Baumann, et al.
Blood|July 11, 2006
High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphomaJoaquim Carreras, Armando Lopez-Guillermo, Bridget C Fox, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphomaJoaquim Carreras, Armando Lopez-Guillermo, Giovanna Roncador, et al.
The American Journal of Pathology|April 25, 2009
Activation of the endoplasmic reticulum stress-associated transcription factor x box-binding protein-1 occurs in a subset of normal germinal-center B cells and in aggressive B-cell lymphomas with prognostic implicationsOlga Balague, Ana Mozos, Daniel Martinez, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 14, 2017
HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphomaBlanca Gonzalez-Farre, Daniel Martinez, Monica Lopez-Guerra, et al.
Journal of Nephrology|January 29, 2014
Primary brain lymphomas after kidney transplantation: an under-recognized problem?Nuria Sola-Valls, Néstor Yesid Rodríguez C, Carola Arcal, et al.
Pageof 7